CAS: 1000995-48-1

Chloramultilide C is a macrolide polyketide, which is a secondary metabolite produced by certain marine bacteria. Specifically, it is derived from the genus Streptomyces, isolated from oceanic environments known for their rich biodiversity and unique chemical ecosystems. The mode of action of chloramultilide C involves inhibiting bacterial protein synthesis, thus exerting its antimicrobial effects by targeting and binding to the bacterial ribosome, which disrupts the translation process. This compound has shown significant activity against a broad spectrum of bacterial pathogens, particularly Gram-positive bacteria. In scientific research, chloramultilide C's properties make it a point of interest for developing new antibacterial therapies, especially in response to rising antibiotic resistance. Its unique structuring and action mechanism provide a novel template for bioengineering and synthetic modification, aiming to enhance its efficacy and expand its spectrum of action. Furthermore, understanding its biosynthetic pathways can facilitate the production of structurally similar compounds with improved pharmacokinetic profiles. As such, chloramultilide C serves not only as a lead compound in drug development but also as a valuable tool in studying marine-derived antibiotics.

Chloramultilide C is a natural product of Chloranthus, Chloranthaceae.